| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.16 | 0.007 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.098 | 0.007 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.007 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.14 | 0.007 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.099 | 0.007 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.008 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.008 |